跳至主要内容
临床试验/JPRN-UMIN000009855
JPRN-UMIN000009855已完成未知

A prospective study of management of chemotherapy induced adverse event for breast cancer. - Management of chemotherapy induced adverse event

Showa University0 个研究点目标入组 36 人开始时间: 2013年1月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
36

研究概览

简要总结

Adverse events : No grade 3-4 myalgia, or peripheral sensory neuropathy was observed in either group. QoL : The time course of the mean QoL scores assessed using FACT-B, FACT-B TOI, and FACT-G. HRQoL were similar in both groups, with no significant differences.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • Exclusion Criteria 1) Hypersensitivity of protocol therapy 2) Uncontrolled infection, diarrhea, bowel obstruction, diabetes, myocardinal infarction, heart failure, pulmonary fibrosis, pneumonitis, cerebrovascular disorder, other. 3) Active brain metastasis 4) Mental disorder 5) Severe myelosupression, renal and hepatic disfunction. 6) ascetic and pleural fluid 7) Pregnant, lactating or declined contraception 8) Patients considered ineligible by the attending physician

研究者

相似试验